BP1142

熊去氧胆酸

British Pharmacopoeia (BP) Reference Standard

• 同義詞: 3α,7β-二羟基-5β-胆酸-24-羧酸, 5β-胆酸-24-羧酸-3α,7β-二醇, 7β-羟基石胆酸, UDCS
• 經驗公式（希爾表示法）: C₂₄H₄₀O₄
• CAS號碼: 128-13-2
• 分子量：: 392.57
• Beilstein: 3219888
• MDL號碼: MFCD00003680
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• API 家族: ursodeoxycholic acid
• 形狀: powder
• 製造商／商標名: BP
• mp: 203-204 °C (lit.)
• 應用: pharmaceutical
• 儲存溫度: 2-8°C
• SMILES 字串: C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
• InChI: 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
• InChI 密鑰: RUDATBOHQWOJDD-UZVSRGJWSA-N
• 基因資訊: human ... NR1H4(9971)

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Ursodeoxycholic acid impurity standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Ursodeoxycholic Acid Capsules

Ursodeoxycholic Acid Tablets

Ursodeoxycholic Acid Oral Suspension

包裝

Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H315,H319
• 防範說明: P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313
• 危險分類: Eye Irrit. 2 - Skin Irrit. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable